Oxidative stress complex syndrome: The dark side of the malnutrition-inflammation complex syndrome

Hemodialysis International

Volumn 11, Issue SUPPL. 1, 2007, Pages

  Morena, Marion ^a   Canaud, Bernard ^a   Terrier, Nathalie ^a   Canaud, Ludovic ^a   Cristol, Jean Paul ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Cardiovascular diseases; Hemodialysis; Inflammation; Malnutrition; Oxidative stress

Indexed keywords

ANTIOXIDANT; OXIDIZING AGENT; RECOMBINANT ERYTHROPOIETIN;

AMYLOIDOSIS; ANEMIA; ATHEROSCLEROSIS; BONE DISEASE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; PROTEIN CALORIE MALNUTRITION; REVIEW; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 33947718151     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2007.00144.x     Document Type: Review

References (59)

1. Kalantar-Zadeh K, Ikizler TA, Block G, et al. Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences. Am J Kidney Dis. 2003; 42:864-881.
2. Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999; 55:1899-1911.
3. Stenvinkel P, Chung SH, Heimburger O, Lindholm B. Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients. Perit Dial Int. 2001; 21(Suppl 3):S157-S162.
4. Kalantar-Zadeh K, Kopple JD, Humphreys MH, Block G. Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant. 2004; 19:1507-1519.
5. Kaysen GA. The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol. 2001; 12:1549-1557.
6. McCarthy DO. Tumor necrosis factor alpha and interleukin-6 have differential effects on food intake and gastric emptying in fasted rats. Res Nurs Health. 2000; 23:222-228.
7. Kaizu Y, Kimura M, Yoneyama T, et al. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis. 1998; 31:93-100.
8. Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis. 1997; 29:658-668.
9. Bologa RM, Levine DM, Parker TS, et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis. 1998; 32: 107-114.
10. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003; 63:793-808.
11. Floege J, Schaffer J, Koch KM, Shaldon S. Dialysis related amyloidosi: A disease of chronic retention and inflammation? Kidney Int. 1992; 38(Suppl): S78-S85.
12. Kazama JJ, Arakawa M, Gejyo F. Synovial inflammatory cells captured 131I-beta 2-microglobulin in patients with dialysis related amyloidosis. Amyloid. 1998; 5:24-29.
13. Kalantar-Zadeh K, McAllister CJ, Lehn RS, et al. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis. 2003; 42:761-773.
14. Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 1999; 33:63-72.
15. Goicoechea M, Martin J, de Sequera P, et al. Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int. 1998; 54:1337-1343.
16. Stenvinkel P, Heimburger O, Lindholm B, et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000; 15:953-960.
17. Qureshi AR, Alvestrand A, Divino-Filho JC, et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 2002; 13(Suppl 1):S28-S36.
18. Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999; 55:648-658.
19. Terrier N, Senecal L, Dupuy AM, et al. Association between novel indices of malnutrition-inflammation complex syndrome and cardiovascular disease in hemodialysis patients. Hemodial Int. 2005; 9:159-168.
20. Becker AE, de Boer OJ, van der Wal AC. The role of inflammation and infection in coronary artery disease. Annu Rev Med. 2001; 52:289-297.
21. Morena M, Terrier N, Jaussent I, et al. Plasma osteoprotegerin is associated with mortality in hemodialysis patients. J Am Soc Nephrol. 2006; 17: 262-270.
22. Kiechl S, Schett G, Wenning G, et al. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation. 2004; 109:2175-2180.
23. Loughrey CM, Young IS, Lightbody JH, et al. Oxidative stress in haemodialysis. Q J Med. 1994; 87:679-683.
24. Canaud B, Cristol JP, Morena M, et al. Imbalance of oxidants and antioxidants in haemodialysis patients. Blood Purif. 1999; 17:99-106.
25. Handelman GJ, Walter MF, Adhikarla R, et al. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int. 2001; 59:1960-1966.
26. Tarng DC, Huang TP, Liu TY, et al. Effect of vitamin E-bonded membrane on the 8-hydroxy 2′-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int. 2000; 58:790-799.
27. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996; 49:1304-1313.
28. Stenvinkel P, Holmberg I, Heimburger O, Diczfalusy U. A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients. Nephrol Dial Transplant. 1998; 13:2594-2600.
29. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int. 1999; 55:389-399.
30. Miyata T, Oda O, Inagi R, et al. Beta 2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest. 1993; 92:1243-1252.
31. Miyata T, Wada Y, Cai Z, et al. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int. 1997; 51:1170-1181.
32. Rice-Evans C, Omorphos S, Baysal E. Sickle cell membranes and oxidative damage. Biochem J. 1986; 237:265-269.
33. Weinstein T, Chagnac A, Korzets A, et al. Haemolysis in haemodialysis patients: Evidence for impaired defence mechanisms against oxidative stress. Nephrol Dial Transplant. 2000; 15:883-887.
34. Siems WG, Sommerburg O, Grune T. Erythrocyte free radical and energy metabolism. Clin Nephrol. 2000; 53(Suppl): S9-S17.
35. Taccone-Gallucci M, Lubrano R, Meloni C, et al. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients. Clin Nephrol. 1999; 52:239-245.
36. Cristol JP, Bosc JY, Badiou S, et al. Erythropoietin and oxidative stress in haemodialysis: Beneficial effects of vitamin E supplementation. Nephrol Dial Transplant. 1997; 12:2312-2317.
37. Eckardt KU. Pathophysiology of renal anemia. Clin Nephrol. 2000; 53(Suppl):S2-S8.
38. Delmas-Beauvieux MC, Combe C, Peuchant E, et al. Evaluation of red blood cell lipoperoxidation in haemodialyzed patients during erythropoietin therapy supplemented or not with iron. Nephron. 1995; 69:404-410.
39. Gallucci MT, Lubrano R, Meloni C, et al. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients. Clin Nephrol. 1999; 52:239-245.
40. Kato A, Odamaki M, Hishida A. Blood 8-hydroxy-2′-deoxyguanosine is associated with erythropoietin resistance in haemodialysis patients. Nephrol Dial Transplant. 2003; 18:931-936.
41. Steinberg D, Parthasarathy S, Carew T, et al. Beyond cholesterol. Modifications of low density lipoproteins that increase its atherogenicity. N Engl J Med. 1989; 320:915-924.
42. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999; 340: 115-126.
43. Sutherland W, Walker R, Ball M, et al. Oxidation of low density lipoproteins from patients with renal failure or renal transplants. Kidney Int. 1995; 48:227-236.
44. Morena M, Cristol JP, Dantoine T, et al. Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients. Nephrol Dial Transplant. 2000; 15: 389-395.
45. Bayes B, Pastor MC, Bonal J, et al. Oxidative stress, inflammation and cardiovascular mortality in haemodialysis - role of seniority and intravenous ferrotherapy: Analysis at 4 years of follow-up. Nephrol Dial Transplant. 2006; 21:984-990.
46. Drueke T, Witko-Sarsat V, Massy Z, et al. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation. 2002; 106:2212-2217.
47. Mody N, Parhami F, Sarafian TA, Demer LL. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med. 2001; 31:509-519.
48. Phan O, Ivanovski O, Nguyen-Khoa T, et al. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice. Circulation. 2005; 112:2875-2882.
49. Nguyen-Khoa T, Massy ZA, De Bandt JP, et al. Oxidative stress and haemodialysis: Role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant. 2001; 16:335-340.
50. Ikizler TA, Morrow JD, Roberts LJ, et al. Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol. 2002; 58: 190-197.
51. Annuk M, Zilmer M, Lind L, et al. Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol. 2001; 12: 2747-2752.
52. Panichi V, Migliori M, De Pietro S, et al. C reactive protein in patients with chronic renal diseases. Renal Failure. 2001; 23: 551-562.
53. Memoli B. Cytokine production in haemodialysis. Blood Purif. 1999; 17:149-158.
54. Canaud B, Bosc JY, Leray H, et al. Microbiologic purity of Dialysate: Rationale and technical aspects. Blood Purif. 2000; 18:200-213.
55. Pereira BJ, Snodgrass BR, Hogan PJ, King AJ. Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes. Kidney Int. 1995; 47: 603-610.
56. Hasselwander O, Young I. Oxidative stress in chronic renal failure. Free Radic Res. 1998; 29:1-11.
57. Ward R, McLeish K. Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol. 1994; 5:1697-1702.
58. Ward R, McLeish K. Hemodialysis with cellulose membranes primes the neutrophil oxidative burst. Artif Organs. 1995; 19: 801-807.
59. DeLeo F, Renee J, Cormick SM, et al. Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J Clin Invest. 1998; 101:455-463.